Syndax Pharmaceuticals Inc (SNDX)
18.82
+0.13
(+0.70%)
USD |
NASDAQ |
Oct 04, 16:00
18.82
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Shareholders Equity (Annual): 554.20M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 554.20M |
| December 31, 2022 | 467.45M |
| December 31, 2021 | 408.37M |
| December 31, 2020 | 252.19M |
| December 31, 2019 | 31.60M |
| December 31, 2018 | 53.05M |
| Date | Value |
|---|---|
| December 31, 2017 | 104.32M |
| December 31, 2016 | 84.14M |
| December 31, 2015 | 66.70M |
| December 31, 2014 | -5.716M |
| December 31, 2013 | 11.85M |
| December 31, 2012 | -29.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
31.60M
Minimum
2019
554.20M
Maximum
2023
342.76M
Average
408.37M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Incyte Corp | 5.190B |
| Trevena Inc | -7.657M |
| Bristol-Myers Squibb Co | 29.43B |
| Arcus Biosciences Inc | 462.00M |
| NovaBay Pharmaceuticals Inc | 3.314M |